Co-Diagnostics has filed a Dual 510(k) premarket notification with the FDA for its Co-Dx PCR Flu A/B & RSV upper...
Dispatch Bio has dosed the first participant in a Phase I trial aimed at evaluating its new immunotherapy, DISP-10, in...
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop treatments for fibro-inflammatory diseases.The post Mediar...
Alteogen has signed an exclusive licensing deal worth up to $365m with a global pharmaceutical company, granting worldwide rights to...
Azra AI and Blackford have formed a partnership to support the progression from imaging-based detection to care coordination for patients...
SystImmune has dosed the first patient in its global Phase III clinical trial, BrenDeLL-Lung01, assessing BL-M14D1 combined with atezolizumab in...
SOPHiA GENETICS and AstraZeneca are to co-develop and launch two companion diagnostics aimed at supporting precision oncology therapies.The post SOPHiA...
Evexta Bio and Roche have partnered on a Phase Ib study investigating the rupitasertib-giredestrant combination in patients with advanced or...
Phylo has collaborated with Chugai Pharmaceutical to implement the Biomni Lab platform within the latter’s drug discovery operations.The post Phylo...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.